Skip to main content

Primary Progressive Aphasia

Primary Progressive Aphasia (PPA) is a rare dementia syndrome that affects a person’s language. Adults of any age can develop PPA, but it is most commonly diagnosed in persons under 65. Individuals with PPA may experience difficulties with word finding, word usage, word order, word comprehension and spelling.

Symptoms & Causes

Read a list of common symptoms and potential causes of Primary Progressive Aphasia.

Learn About PPA Symptoms & Causes

Diagnosis

Find out what evaluations may be involved in making a diagnosis.

Learn About PPA Diagnosis

Care, Support & Treatment

Learn more about treatment options and explore our support services.

Learn About PPA Care & Support

Research on Primary Progressive Aphasia

Male researcher talking to female researcher

Research Studies

Those living with Primary Progressive Aphasia should consider enrolling in a research program affiliated with the center. Browse our list of ongoing studies recruiting new participants.

ABOUT PPA RESEARCH JOIN A STUDY

Primary Progressive Aphasia Care & Support

PPA Support Group

We offer support programs for individuals and families affected by neurocognitive diseases, including caregivers. One is specifically designed for those caring for people with Primary Progressive Aphasia.

ABOUT THE GROUP

PPA support group meeting and caring

PPA Participant Art Gallery

gallery of artwork made by PPA research participants

Many of our PPA research participants have left behind a unique gift for the Mesulam Center — their artwork. We have compiled a gallery of selected artwork from past and current participants.

Discover how art offers a profound, enduring means of communication and expression amidst language loss.

VIEW PPA PARTICIPANT ART GALLERY

Publications on Primary Progressive Aphasia

Discovery of PPA’s Pathological Signature

Discovery of PPA’s Pathological Signature

“When you are able to understand the underlying pathology, only then can you find a treatment. You first have to disentangle the complex relationship between the symptoms experienced by the patient and the actual disease that destroys cells in the brain.”
 — Tamar Gefen, PhD, lead investigator of a new publication in the Journal of Neuropathology & Experimental Neurology 

Read the full story

Giving

Your generous support can make a big impact.

Follow Mesulam Institute on Facebook